Provided by Tiger Trade Technology Pte. Ltd.

Kamada

7.08
-0.0300-0.42%
Post-market: 7.080.00000.00%16:10 EST
Volume:55.74K
Turnover:393.64K
Market Cap:408.39M
PE:20.25
High:7.24
Open:7.14
Low:6.99
Close:7.11
52wk High:9.16
52wk Low:5.54
Shares:57.68M
Float Shares:9.36M
Volume Ratio:0.83
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3496
EPS(LYR):0.2516
ROE:7.86%
ROA:4.76%
PB:1.54
PE(LYR):28.14

Loading ...

Kamada Ltd. Amends Shareholder Meeting Notice and Voting Procedures

Reuters
·
Dec 02

Kamada’s Growth Potential and Strategic Development Justify Buy Rating

TIPRANKS
·
Nov 12

Kamada Ltd. Reports Strong Financial Growth in 2025

TIPRANKS
·
Nov 11

Kamada Ltd. Reports Strong Growth Amid Challenges

TIPRANKS
·
Nov 11

Kamada Q3 2025 Earnings Call Summary and Q&A Highlights: Strong Revenue Growth and Strategic Expansion

Earnings Call
·
Nov 10

Kamada (KMDA) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 10

Kamada sees FY25 revenue $178M-$182M

TIPRANKS
·
Nov 10

Kamada Q3 EPS $0.09 Misses $0.10 Estimate, Sales $47.010M Beat $45.811M Estimate

Benzinga
·
Nov 10

Biopharma firm Kamada's Q3 revenue up 13%, beats estimates

Reuters
·
Nov 10

Press Release: Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

Dow Jones
·
Nov 10

Kamada Ltd expected to post earnings of 9 cents a share - Earnings Preview

Reuters
·
Nov 07

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation

TIPRANKS
·
Nov 04

Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation

GlobeNewswire
·
Nov 04

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025

GlobeNewswire
·
Nov 03

Kamada to Present at the Stifel 2025 Healthcare Conference

GlobeNewswire
·
Oct 29

Kamada Ltd. Announces Date for Annual General Meeting of Shareholders

Reuters
·
Oct 23

Kamada Ltd. to Present at Wells Fargo Healthcare and H.C. Wainwright Global Investment Conferences

Reuters
·
Sep 02

Kamada Ltd reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

Biopharma firm Kamada's Q2 profit beats expectations

Reuters
·
Aug 13

Kamada Q2 2025 EPS $0.13 Beats $0.09 Estimate, Sales $38.436M Miss $44.667M Estimate

Benzinga
·
Aug 13